Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Plasma from COVID-19 survivors tested as treatment for the critically ill

NCT ID NCT04376034

First seen May 31, 2026 · Last updated Jun 17, 2026 · Updated 3 times

Summary

This study looked at whether giving plasma (the liquid part of blood) from people who recovered from COVID-19 could help critically ill patients fight the virus. The plan was to collect plasma from up to 240 recovered donors and give it to sick patients. However, the plasma donation part was not completed because the state lacked the needed equipment and approvals. The study still tracked how long it took to identify donors and how well patients survived after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID -19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • WVU Medicine

    Morgantown, West Virginia, 26506, United States

Conditions

The condition(s) this trial relates to.

Coronavinae infectious disease COVID-19 RNA Virus Infections viral infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.